. , Partie II Les principales classes pharmacologiques néphrotoxiques à l'officine

.. .. Les,

.. .. Les,

.. .. Les,

.. .. Les,

.. .. Les,

.. .. Les,

.. .. Les,

. .. Les-nitro-imidazolés,

.. .. Les,

.. .. Les, 1.2. Conduite à tenir en cas de risque de néphrotoxicité sous AINS, 1. Les anti-inflammatoires non stéroïdiens (AINS)
URL : https://hal.archives-ouvertes.fr/hal-02051623

.. .. Les,

.. .. Le-paracétamol,

. .. Les-dérivés-opiacés,

. , Les médicaments utilisés dans le traitement de l'hypertension artérielle ou la

. , Les inhibiteurs de l'enzyme de conversion (IEC) et les antagonistes de l'angiotensine II

.. .. Les,

.. .. Les,

.. .. Les-produits-de-contraste-iodés,

. , Inhibiteurs de la pompe à proton (IPP), Les produits disponibles à l'officine sans ordonnance

. , Partie III Place du pharmacien d'officine dans la prévention de la néphrotoxicité des médicamentsPartie III Place du pharmacien d'officine dans la prévention de la néphrotoxicité

.. .. Considérations,

D. Le-pharmacien, officine a-t-il un rôle à jouer ?

. .. Rôle-du-pharmacien-d'officine-dans-la-prévention-de-la-néphrotoxicité, 67 2.1. Conseils et prévention lors de la délivrance de médicaments néphrotoxiques

. .. Prévenir-la-déshydratation,

. , Eviter les associations de médicaments néphrotoxiques

.. .. Déclarer-les-effets-indésirables,

.. .. Conseils-hygiéno-diététiques,

. , Propositions d'amélioration du rôle du pharmacien d'officine dans la prévention de la néphrotoxicité

. .. Etat-des-lieux,

. , 2.5. L'évolution de nos logiciels de dispensation, Améliorer les outils à la disposition des pharmaciens d'officine

?. .. Que-manque-t-il-au-pharmacien-d'officine-pour-s'impliquer-davantage, 3.2. Manque de sensibilisation des médecins au rôle du pharmacien, vol.87

. .. Conclusion,

. .. Annexes,

. .. Bibliographie, , vol.114, p.4

. Le, en cas de traitement intermittent, un risque d'IRA habituellement due à une NTA réversible et un cas de nécrose corticale

B. Marc, P. Miroux, I. Piedade, and B. , Guide infirmier des urgences, vol.1, pp.100-103, 2008.

M. L. Bentley, H. L. Corwin, and J. Dasta, Drug-induced acute kidney injury in the critically ill adult : recognition and prevention strategies, Crit Care Med, vol.38, pp.169-74, 2010.

, Iatrogénie en néphrologie. Diagnostic et prévention. 7 ème ed, Mise à jour Aout, 2016.

M. Daudon, O. Traxer, P. Jungers, and . Lithiase, , vol.2, pp.608-625

M. A. Perazella, Crystal-induced acute renal failure, Am J Med, vol.106, issue.4, pp.459-65, 1999.

P. Jungers, M. Daudon, and L. Duc, , vol.1989, pp.408-424, 2018.

, Site GPR Guide des Prescription et Rein, 2018.

J. L. Potter and A. A. Silvidi, Band PR, Silverberg DS et Henderson JF. Xanthine nephropathy in a patient with lymphosarcoma treated with allopurinol, N Engl J Med, vol.33, issue.36, pp.354-361, 1970.

J. J. Boffa, D. Preneuf, H. Bouadma, and L. , Acute renal failure after amoxicillin crystallization, Presse Med, vol.29, issue.13, pp.699-701, 2000.

M. Boursas, L. Benhassine, and J. Kempf, Obstructive renal insufficiency caused by amoxicillin crystalluria, Ann Fr Anesth Reanim, vol.16, issue.7, pp.908-918, 1997.

Z. Avci, A. Koktener, and N. Uras, Nephrolithiasis associated with ceftriaxone therapy: a prospective study in 51 children, Arch Dis Child, vol.89, issue.11, pp.1069-72, 2004.

T. Kimata, K. Kaneko, M. Takahashi, M. Hirabayashi, T. Shimo et al., Increased urinary calcium excretion caused by ceftriaxone : possible association with urolithiasis, Pediatr Nephrol, vol.27, issue.4, pp.605-614, 2012.

X. Lu, R. Wu, X. Huang, and Y. Zhang, Noncontrast multidetector-row computed tomography scanning for detection of radiolucent calculi in acute renal insufficiency caused by bilateral ureteral obstruction of ceftriaxone crystals, J Xray Sci Technol, vol.20, issue.1, pp.11-17, 2012.

H. Xie, H. Chen, Y. Hu, S. Xu, Q. He et al., Clindamycin-induced acute kidney injury : large biopsy case series, Am J Nephrol, vol.38, issue.3, pp.179-83, 2013.

H. Izzedine, K. Svetlana, V. Launay-vacher, and D. Derray, Néphrotoxicité des médicaments : veille bibliographique janvier 2003-décembre, Néphrol Ther, vol.2, issue.6, pp.368-78, 2005.

B. D. Mcgettigan, M. Hew, E. Phillips, and A. Mclean-tooke, Sulphadiazine-induced renal stones in a 63-year-old HIV-infected man treated for toxoplasmosis, BMJ Case Rep, 2012.

S. G. Yarlagadda, M. Perazella, F. J. Alvarez, P. Gallardo, A. M. et al., Acute renal failure due to sulfadiazine crystalluria, Expert Opin Drug Saf, vol.7, issue.2, pp.235-243, 2007.

H. Hyvernat, P. De-swardt, V. Mondain, and G. Bernardin, Acute obstructive kidney failure during sulfadiazine treatment, Presse Med, vol.35, issue.3, pp.423-427, 2006.

F. Díaz, J. Collazos, J. Mayo, and E. Martínez, Sulfadiazine-induced multiple urolithiasis and acute renal failure in a patient with AIDS and Toxoplasma encephalitis, Ann Pharmacother, vol.30, issue.1, pp.41-43, 1996.

M. Daudon and P. Jungers, Drug-induced renal calculi : epidemiology, prevention and management, Drugs, vol.64, pp.245-75, 2004.
DOI : 10.2165/00003495-200464030-00003

K. Becker, H. Jablonowski, and D. Haussinger, Sulfadiazine-associated nephrotoxicity in patients with the acquired immunodeficiency syndrome, Medicine, vol.75, pp.185-94, 1996.

J. Guitard, N. Kamar, and M. Mouzin, Sulfadiazine-related obstructive urinary tract lithiasis : an unusual cause of acute renal failure after kidney transplantation, Clin Nephrol, vol.63, issue.5, pp.405-412, 2005.
DOI : 10.5414/cnp63405

J. Allinson, W. Topping, S. G. Edwards, and R. F. Miller, Sulphadiazine-induced obstructive renal failure complicating treatment of HIV-associated toxoplasmosis, Int J STD AIDS, vol.23, issue.3, pp.210-212, 2012.
DOI : 10.1258/ijsa.2009.009539

A. Schwarz and A. Perez-canto, Nephrotoxicity of anti-infective drugs, Int J Clin Pharmacol Ther, vol.36, issue.3, pp.164-171, 1998.

W. H. Siegal, Unusual complication of therapy with sulfamethoxazole-trimethoprim, J Urol, vol.117, p.397, 1977.

F. , M. A. Amodio-groton, M. I. Catalano, and M. T. , Adverse reactions to trimethoprim/sulfamethoxazole in AIDS, Ann Pharmacother, vol.37, issue.12, pp.1810-1813, 2003.

J. Demichele, H. Rezaizadeh, and J. I. Goldstein, Sulfasalazine crystalluria-induced anuric renal failure, Clin Gastroenterol Hepatol, vol.10, issue.2, p.32, 2012.

D. Fries, P. Druet, A. Fournier, and M. Paillard, Maladies rénales. Paris : Hermann édtiteurs des siences et des arts, p.644, 1992.

N. Chopra, P. L. Fine, B. Price, and I. Atlas, Bilateral hydronephrosis from ciprofloxacin induced crystalluria and stone formation, J Urol, 2000.

J. S. Berns, R. M. Cohen, and R. J. Stumacher, Renal aspects of therapy for human immunode ciency virus and associated opportunistic infections, J Am Soc Nephrol, vol.1, pp.1061-80, 1991.

M. H. Sawyer, D. E. Webb, J. E. Balow, and S. E. Straus, Acyclovir-induced renal failure. Clinical course and histology, Am J Med, vol.84, issue.6, pp.1067-71, 1988.
DOI : 10.1016/0002-9343(88)90313-0

URL : https://zenodo.org/record/1253778/files/article.pdf

E. N. Obada, G. Level, P. Mathieu, X. Parent, B. Gilson et al., Acute renal failure following a treatment with acyclovir, Nephrol Ther, vol.6, issue.2, pp.125-132, 2010.

B. Bean and D. Aeppli, Adverse effects of high-dose intravenous acyclovir in ambulatory patients with acute herpes zoster, J Infect Dis, vol.151, pp.362-367, 1985.

J. Liotier, B. Souweine, and P. Deteix, Drug-induced acute renal failure, EMC-Néphrologie, vol.1, pp.137-179, 2004.

H. Izzedine, V. Laney-vacher, G. Deray, G. M. Schmidt, D. A. Horak et al., Guide des prescriptions des médicaments chez le patient insuffisant rénal. Antiviraux. Paris : Broché ; 2003 :199. (65) The City of Hope-Stanford-Syntex CMV Study Group, N Engl J Med, vol.324, pp.1005-1016, 1991.

A. J. Olyaei, A. M. Demattos, and W. M. Bennett, Renal toxicity of protease inhibitors, Curr Opin Nephrol Hypertens, vol.9, pp.473-479, 2000.

C. C. Szeto and K. M. Chow, Nephrotoxicity related to new therapeutic compounds, Ren Fail, vol.27, issue.3, pp.329-362, 2005.

H. Izzedine, M. Harris, and M. A. Perazella, The nephrotoxic effects of HAART, Nat Rev Nephrol, vol.5, issue.10, pp.563-73, 2009.

R. Kalyesubula and M. A. Perazella, Nephrotoxicity of HAART, AIDS Res Treat, p.562790, 2011.

H. R. Chang and P. M. Pella, Atazanavir urolithiasis, N Engl J Med, vol.355, pp.2158-2167, 2006.
DOI : 10.1056/nejmc061892

G. Deray, F. Martinez, C. Katlama, B. Levaltier, H. Beaufils et al., Foscarnet nephrotoxicity : mechanism, incidence and prevention, Am J Nephrol, vol.9, pp.316-337, 1989.
DOI : 10.1159/000167987

L. Maurice-estepa, M. Daudon, and C. Katlama, Identification of crystals in kidneys of AIDS patients treated with foscarnet, Am J Kidney Dis, vol.32, issue.3, pp.392-400, 1998.

G. Deray, M. Bochet, and C. Katlama, Néphrotoxicité du ritonavir, Presse Med, vol.27, pp.1801-1812, 1998.

C. M. Kalorin, R. Bauer, and M. D. White, Phenytoin metabolite renal calculus: an index case, J Endourol, vol.22, issue.8, pp.1665-1673, 2008.
DOI : 10.1089/end.2007.0410

A. Waness, S. Bahlas, A. Shohaib, and S. , Simvastatin-induced rhabdomyolysis and acute renal injury, Blood Purif, vol.26, pp.394-402, 2008.
DOI : 10.1159/000141931

URL : https://www.karger.com/Article/Pdf/141931

A. Klisnick, J. Fourcade, M. Ruivard, J. P. Kains, J. C. Hardy et al., Combined idiopathic retroperitoneal and mediastinal fibrosis with pericardial involvement, Clin Nephrol, vol.52, issue.1, pp.51-56, 1999.

, Flammarion Médecine Science, 78) Noël LH. Atlas de pathologie rénale, vol.45, pp.306-316, 1990.

P. Cochat and L. Dubourg, Rein et médicaments. EMC-Pédiatrie, vol.1, issue.2, pp.171-85, 2004.

L. Jacob, Rhabdomyolysis and acute renal failure during high-dose haloperidol therapy, Ren Fail, vol.17, issue.81, pp.475-483, 1995.

L. A. Linares, B. A. Golomb, J. A. Jaojoco, H. Sikand, and P. S. Phillips, The modern spectrum of rhabdomyolysis : drug toxicity revealed by creatine kinase screening, Curr Drug Saf, vol.4, issue.3, pp.181-188, 2009.

A. Zhao, M. Tan, A. Maung, M. Salifu, and M. Mallappallil, Rhabdomyolysis and Acute Kidney Injury Requiring Dialysis as a Result of Concomitant Use of Atypical Neuroleptics and Synthetic Cannabinoids, Case Rep Nephrol, p.235982, 2015.

M. Richard, M. R. Lattanzio, and N. P. Kopyt, Acute kidney injury : new concepts in de nition, diagnosis, pathophysiology, and treatment, Médicaments néphrotoxiques pouvant entrainer une insuffisance rénale aigüe Th. : Pharm. : Rennes, vol.15, pp.13-22, 2006.

A. Meyrier, Maladie rénale de l'adulte. Paris : Editeur des préparation grandes écoles médecine, p.479, 1993.

L. Kovacevic, J. Bernstein, R. P. Valentini, A. Imam, N. Gupta et al., Renal papillary necrosis induced by naproxen, Pediatr Nephrol, vol.18, issue.8, pp.826-835, 2003.

B. N. Becker, P. Fall, and C. Hall, Rapidly progressive acute renal failure due to acyclovir : case report and review of the literature, Am J Kidney Dis, vol.22, pp.611-616, 1993.

G. Alexandridis, E. Liberopoulos, and M. Elisaf, Aminoglycoside-indu-ced reversible tubular dysfunction, Pharmacology, vol.67, pp.118-138, 2003.

Y. Berland and B. Dussol, Néphrologie pour l'interne. Tome 3. Facculté de médecine de marseille, Pharmacotherapy, vol.24, issue.91, pp.808-819, 2000.

H. Wan, Z. Hu, J. Wang, S. Zhang, X. Yang et al., Clindamycin-induced Kidney Diseases : A Retrospective Analysis of 50 Patients, Intern Med, vol.55, issue.11, pp.1433-1440, 2016.

E. Zuliani, H. Zwahlen, F. Gilliet, and C. Marone, Vancomycin-induced hypersensitivity reaction with acute renal failure : resolution following cyclosporine treatment, Clin Nephrol, vol.64, pp.155-163, 2005.

C. Y. Wu, J. S. Wang, Y. H. Chiou, C. Y. Chen, and Y. T. Su, Biopsy proven acute tubular necrosis associated with vancomycin in a child : case report and literature review, Ren Fail, vol.29, issue.8, pp.1059-61, 2007.

P. Meier, S. Dautheville-guibal, P. M. Ronco, and J. Rossert, Cidofovir-induced end-stage renal failure, Nephrol Dial Transplant, vol.17, pp.148-157, 2002.

S. D. Baek, S. J. Jang, S. E. Park, T. J. Ok, J. Leem et al., Fatal rhabdomyolysis in a patient with liver cirrhosis after switching from simvastatin to fluvastatin, J Korean Med Sci, vol.26, issue.12, pp.1634-1641, 2011.

A. Waness, S. Bahlas, A. Shohaib, and S. , Simvastatin-induced rhabdomyolysis and acute renal injury, Blood Purif, vol.26, issue.4, pp.394-402, 2008.

F. A. Qari, Severe rhabdomyolysis and acute renal failure secondary to use of simvastatin in undiagnosed hypothyroidism, Saudi J Kidney Dis Transpl, vol.20, issue.1, pp.127-136, 2009.

A. Tufan, D. S. Dede, S. Cavus, N. D. Altintas, A. B. Iskit et al., Rhabdomyolysis in a patient treated with colchicine and atorvastatin, Ann Pharmacother, vol.40, issue.7-8, pp.1466-1475, 2006.

D. P. Kao, H. E. Kohrt, and J. Kugler, Renal failure and rhabdomyolysis associated with sitagliptin and simvastatin use, Diabet Med, vol.25, issue.10, pp.1229-1259, 2008.

M. Hayman, E. C. Seidl, M. Ali, and K. Malik, Acute tubular necrosis associated with propylene glycol from concomitant administration of intravenous lorazepam and trimethoprim-sulfamethoxazole, Pharmacotherapy, vol.23, issue.9, pp.1190-1194, 2003.

J. S. Berns, A. Haghighat, and A. Staddon, Severe, irreversible renal failure after ifosfamide treatment. A clinicopathologic report of two patients, Cancer, vol.76, issue.3, pp.497-500, 1995.

B. Domangé, Néphrotoxicité sous-estimée du paracétamol : à propos de 9 observations Th, 2016.

P. Blakely and B. R. Mcdonald, Acute renal failure due to acetaminophen ingestion: a case report and review of the literature, J Am Soc Nephrol, vol.6, issue.1, pp.48-53, 1995.

A. Davenport and R. Finn, Paracetamol (acetaminophen) poisoning resulting in acute renal failure without hepatic coma, Nephron, 1988.

R. Gabriel, J. Caldwell, and R. B. Hartley, Acute tubular necrosis, caused by therapeutic doses of paracetamol?, Clin Nephrol, vol.18, issue.5, pp.269-71, 1982.

M. Shapiro, K. M. Ward, and J. J. Stern, A near-fatal hypersensitivity reaction to abacavir: case report and literature review, AIDS Read, vol.11, issue.4, pp.222-228, 2001.

M. A. Crowther, W. Callaghan, A. B. Hodsman, and I. D. Mackie, Dideoxyinosine-associated nephrotoxicity, AIDS, vol.7, pp.131-133, 1993.

H. Izzedine, V. Launay-vacher, and G. Deray, Fanconi syndrome associated with didanosine therapy, AIDS, vol.19, pp.844-849, 2005.

D. Dubois-laforgue, D. Boutboul, D. J. Lévy, D. Joly, and J. Timsit, Severe acute renal failure in patients treated with glucagon-like peptide-1 receptor agonists, Diabetes Res Clin Pract, vol.103, issue.3, pp.53-58, 2014.

A. Barracca, O. Ledda, B. Michittu, G. F. Pili, O. Manca et al., Acute renal failure after massive ingestion of gliclazide in a suicide attempt, Ren Fail, vol.20, issue.3, pp.533-540, 1998.

S. Pozzi and N. Raje, The role of bisphosphonates in multiple myeloma : mechanisms, side effects, and the future, Oncologist, vol.16, issue.5, pp.651-62, 2011.

P. Jubert, J. Almirall, A. Casanovas, and M. Garcia, Carbamazepine-induced acute renal failure, Nephron, vol.66, issue.1, p.121, 1994.

R. J. Baker and C. D. Pusey, The changing profile of acute tubuloin-terstitial nephritis, Nephrol Dial Transplant, vol.19, pp.8-11, 2004.

J. Nortier, M. Depierreux, and V. Bourgeois, Progression of a naproxen and amoxicillin induced acute interstitial nephritis with nephrotic syndrom: case report, Clin Nephrol, vol.35, pp.187-196, 1991.

B. Stengel and P. Simon, Insuffisance rénale chronique : étiologies, moyens de diagnostic précoce, prévention ? Paris : Les éditions Inserm, pp.141-56, 1998.

G. M. Bell and D. Thomson, Acute interstitial nephritis associated with gentamicin and lincomycin therapy, Postgrad Med J, vol.56, issue.656, pp.445-452, 1980.

G. B. Appel, G. Garvey, and F. Silva, Reversible renal failure in female patients with acute interstitial nephritis caused by cloxacillin, Pol Tyg Lek, vol.27, issue.6, pp.1113-1117, 1981.

R. Garcia-ortiz, R. S. Espinoza, G. R. Silva, R. K. Alonso, H. S. Opazo et al., Cloxacillin-induced acute tubulo interstitial nephritis, Ann Pharmacother, vol.26, issue.10, pp.1241-1243, 1992.

J. R. Burton, N. S. Lichtenstein, and R. B. Colvin, Acute interstitial nephritis from oxacillin, Johns Hopkins Med J, vol.134, issue.1, pp.58-61, 1974.

D. Tillman, P. A. Oill, and L. B. Gurze, Oxacillin nephritis, Arch Intern Med, vol.140, issue.11, p.1552, 1980.

H. Tanaka, S. Waga, Y. Kakizaki, T. Tateyama, M. Koda et al., Acute tubulointerstitial nephritis associated with piperacillin therapy in a boy with glomerulonephritis, Acta Paediatr Jpn, vol.39, issue.6, pp.698-700, 1997.

M. W. Pill, O. Neill, C. V. Chapman, M. M. Singh, and A. K. , Suspected acute interstitial nephritis induced by piperacillin-tazobactam, Pharmacotherapy, vol.17, issue.1, pp.166-175, 1997.

O. Dörner, C. Piper, H. P. Dienes, P. A. Berg, V. Egidy et al., Acute interstitial nephritis following piperacillin, Klin Wochenschr, vol.67, issue.13, pp.682-688, 1989.

J. A. Pratt, M. K. Stricherz, P. S. Verghese, and M. J. Burke, Suspected piperacillin-tazobactam induced nephrotoxicity in the pediatric oncology population. Pediatr Blood Cancer, vol.61, pp.366-374, 2014.

W. Pommer, P. H. Krause, P. A. Berg, H. H. Neumayer, M. J. Mihatsch et al., Acute interstitial nephritis and non-oliguric renal failure after cefaclor treatment, Klin Wochenschr, vol.64, issue.6, pp.290-293, 1986.

J. K. Goddard, S. W. Janning, J. S. Gass, and R. F. Wilson, Cefuroxime-induced acute renal failure, Pharmacotherapy, vol.14, issue.4, pp.488-91, 1994.

G. Zanetti, F. Bally, G. Greub, J. Garbino, T. Kinge et al.,

, Cefepime versus imipenem-cilastatin for treatment of nosocomial pneumonia in intensive care unit patients: a multicenter, evaluator-blind, prospective, randomized study, Antimicrob Agents Chemother, vol.47, issue.11, pp.3442-3449, 2003.

J. F. Ladagnous, J. M. Rousseau, A. Gaucher, J. M. Saïssy, and R. Pitti, Acute interstitial nephritis. Role of ceftazidime, Ann Fr Anesth Reanim, vol.15, issue.5, pp.677-80, 1996.

R. Plakogiannis and A. Nogid, Acute interstitial nephritis associated with coadministration of vancomycin and ceftriaxone: case series and review of the literature, Pharmacotherapy, vol.27, issue.10, pp.1456-61, 2007.

E. Demirkaya, A. A. Atay, U. Musabak, A. Sengul, and F. Gok, Ceftriaxone-related hemolysis and acute renal failure, Pediatr Nephrol, vol.21, issue.5, pp.733-739, 2006.
DOI : 10.1007/s00467-006-0043-4

S. Shohaib, M. S. Satti, and Z. Abunijem, Acute interstitial nephritis due to cefotaxime, Nephron, vol.73, issue.4, p.725, 1996.

S. L. Ding, R. R. Bailey, and J. Gardner, Acute interstitial nephritis and acute renal failure following erythromycin treatment : case report, N Z Med J, vol.109, issue.2, p.244, 1028.

R. Enriquez, F. Berisa, S. Moreno, C. Salva, M. et al., Acute interstitial nephritis caused by erythromycin

, Med Clin (Barc), vol.82, issue.4, pp.182-185, 1984.

J. Rosenfeld, V. Gura, G. Boner, M. Ben-bassat, and E. Livni, Interstitial nephritis with acute renal failure after erythromycin, Br Med J (Clin Res Ed), vol.286, issue.6369, pp.938-947, 1983.
DOI : 10.1136/bmj.286.6369.938

URL : https://www.bmj.com/content/286/6369/938.full.pdf

P. Baylor and K. Williams, Interstitial nephritis, thrombocytopenia, hepatitis, and elevated serum amylase levels in a patient receiving clarithromycin therapy, Clin Infect Dis, vol.29, issue.5, pp.1350-1351, 1999.
DOI : 10.1086/313475

URL : https://academic.oup.com/cid/article-pdf/29/5/1350/987937/29-5-1350.pdf

N. Soni, J. W. Harrington, R. Weiss, P. Chander, and S. Vyas, Recurrent acute interstitial nephritis induced by azithromycin, Pediatr Infect Dis J, vol.23, pp.965-971, 2004.
DOI : 10.1097/01.inf.0000141753.41486.ff

A. E. Woodruff, C. J. Meaney, E. A. Hansen, and G. M. Prescott, Azithromycin-Induced, Biopsy-Proven Acute Interstitial Nephritis in an Adult Successfully Treated with Low-Dose Corticosteroids, Pharmacotherapy, vol.35, issue.11, pp.169-74, 2015.

C. Persico, A. Rocchi, A. Edefonti, G. P. Milani, M. B. Mazzoni et al., The acute interstitial nephritis induced by azithromycin, NDT Plus, vol.4, issue.3, p.218, 2011.
DOI : 10.1093/ndtplus/sfr013

URL : https://academic.oup.com/ckj/article-pdf/4/3/218/987247/sfr013.pdf

G. A. Mansoor, B. J. Panner, and D. B. Ornt, Azithromycin-induced acute interstitial nephritis, Ann Intern Med, vol.119, issue.7, pp.636-643, 1993.
DOI : 10.7326/0003-4819-119-7_part_1-199310010-00027

C. Cryst and S. P. Hammar, Acute granulomatous interstitial nephritis due to co-trimoxazole, Am J Nephrol, vol.8, pp.483-491, 1988.
DOI : 10.1159/000167666

M. Agharazii, Chronic interstitial nephritis due to 5-aminosalicylic acid, Am J Nephrol, vol.19, issue.3, pp.373-379, 1999.
DOI : 10.1159/000013480

G. Corrigan and P. E. Stevens, Review article: interstitial nephritis associated with the use of mesalazine in inflammatory bowel disease

, Aliment Pharmacol Ther, vol.14, issue.1, pp.1-6, 2000.

A. D. Dwarakanath, J. Michael, and R. N. Allan, Sulphasalazine induced renal failure, Gut, vol.33, issue.7, pp.1006-1013, 1992.
DOI : 10.1136/gut.33.7.1006

URL : https://gut.bmj.com/content/33/7/1006.full.pdf

J. F. Augusto, J. Sayegh, A. Simon, A. Croue, J. M. Chennebault et al., A case of sulphasalazine-induced DRESS syndrome with delayed acute interstitial nephritis, Nephrol Dial Transplant, vol.24, issue.9, pp.2940-2942, 2009.

L. J. Arend and J. E. Springate, Interstitial nephritis from mesalazine : case report and literature review, Pediatr Nephrol, vol.19, issue.5, pp.550-553, 2004.
DOI : 10.1007/s00467-004-1411-6

P. Alivanis, G. Aperis, F. Lambrianou, A. Zervos, C. Paliouras et al., Reversal of refractory sulfasalazine-related renal failure after treatment with corticosteroids, Clin Ther, vol.32, issue.11, pp.1906-1916, 2010.

B. A. Lipsky and C. A. Baker, Fluoroquinolone toxicity profiles : a review focusing on newer agents, Clin Infect Dis, vol.28, issue.2, pp.352-64, 1999.

J. R. Bailey, S. A. Trott, and J. T. Philbrick, Ciprofloxacin-induced acute interstitial nephritis, Am J Nephrol, vol.12, issue.4, pp.271-274, 1992.

M. Argirov, G. Ricken, D. Zecher, and M. Fischereder, Acute interstitial nephritis associated with moxifloxacin use, Clin Ther, vol.27, issue.8, pp.1260-1263, 2005.
DOI : 10.1016/j.clinthera.2005.08.008

C. Chatzikyrkou, I. Hamwi, C. Clajus, J. Becker, C. Hafer et al., Biopsy proven acute interstitial nephritis after treatment with moxifloxacin, BMC Nephrol, vol.11, p.19, 2010.

G. Famularo, D. Simone, and C. , Nephrotoxicity and purpura associated with levofloxacin, Ann Pharmacother, vol.36, issue.9, pp.1380-1382, 2002.
DOI : 10.1345/1542-6270(2002)036<1380:napawl>2.0.co;2

S. Ramalakshmi, S. Bastacky, and J. P. Johnson, Levofloxacin-induced granulomatous interstitial nephritis, Am J Kidney Dis, vol.41, issue.2, p.7, 2003.
DOI : 10.1053/ajkd.2003.50064

N. M. Solomon and M. H. Mokrzycki, Levofloxacin-induced allergic interstitial nephritis, Clin Nephrol, vol.54, p.356, 2000.

M. Nakamura, A. Ohishi, N. Aosaki, and K. Hamaguchi, (158) Lomaestro BM. Fluoroquinolone-induced renal failure, Drug Saf, vol.86, issue.2, pp.479-85, 2000.

M. M. Bergman, R. H. Glew, and T. H. Ebert, Acute interstitial nephritis associated with vancomycin therapy, Arch Intern Med, vol.148, pp.2139-2179, 1988.
DOI : 10.1001/archinte.148.10.2139

H. Kallel, C. B. Hamida, H. Ksibi, M. Bahloul, L. Hergafi et al., Suspected acute interstitial nephritis induced by colistin, J Nephrol, vol.18, issue.3, pp.323-329, 2005.

S. Rosati, C. Cherubini, F. Iacomi, K. Giannakakis, L. Vincenzi et al., Acute rifampicin-associated interstitial tubulopathy in a patient with pulmonary tuberculosis : a case report, J Med Case Rep, vol.7, issue.1, p.106, 2013.

M. Krishnan, R. Nair, M. Haas, and M. G. Atta, Acute renal failure in an HIV-positive 50-year-old man, Am J Kidney Dis, vol.36, pp.1075-1083, 2000.

M. S. Lee, A. K. Lau, G. Crosland, and R. Caterson, Renal impairment associated with oral terbinafine, Br J Dermatol, vol.134, issue.2, pp.374-379, 1996.
DOI : 10.1111/j.1365-2133.1996.tb07638.x

J. A. Abadin, J. A. Duran, and J. A. Perez-de-leon, Probable diltiazem-induced acute interstitial nephritis, Ann Pharmacother, vol.32, pp.656-664, 1998.

A. A. Ejaz, P. M. Fitzpatrick, and W. E. Haley, Amlodipine besylate induced acute interstitial nephritis, Nephron, vol.85, pp.354-360, 2000.
DOI : 10.1159/000045688

N. Torpey, T. Barker, and C. Ross, Drug-induced tubulo-interstitial nephritis secondary to proton pump inhibitors : experience from a single UK renal unit, Nephrol Dial Transplant, vol.19, pp.1441-1447, 2004.

A. Martinez-vea, M. J. Herranz, and A. Llorente, Acute renal failure with chronic lymphocytic leukaemia, Postgrad Med J, vol.72, pp.763-768, 1996.
DOI : 10.1136/pgmj.72.854.763

URL : https://pmj.bmj.com/content/postgradmedj/72/854/763.full.pdf

A. Dantec, J. S. Virot, A. Filancia, R. Angonin, and H. Nefti, Néphrite tubulo-interstitielle au RIVAROXABAN (XARELTO). La presse médicale, vol.46, pp.541-543, 2017.
DOI : 10.1016/j.lpm.2017.03.019

E. Eguchi, K. Shimazu, K. Nishiguchi, S. Yorifuji, A. Tanaka et al., Granulomatous interstitial nephritis associated with atypical druginduced hypersensitivity syndrome induced by carbamazepine, Clin Exp Nephrol, vol.16, issue.1, pp.168-72, 2012.

L. L. Fruchter, I. Alexopoulou, and K. K. Lau, Acute interstitial nephritis with acetaminophen and alcohol intoxication, Ital J Pediatr, vol.37, p.17, 2011.

G. Jickling, A. Heino, and S. N. Ahmed, Acetaminophen toxicity with concomitant use of carbamazepine, Epileptic Disord, vol.11, issue.4, pp.329-361, 2009.

B. Szp6e, C. Trinn, T. Toth, H. Brasch, and J. Nagy, Paracetamol-induced tubulointerstitial nephritis in a chronic alcoholic patient, Orv Hetil, vol.139, issue.40, pp.2385-2392, 1998.

F. Martinez, H. Mommeja-marin, L. Estepa-maurice, H. Beaufils, M. Bochet et al., Indinavir crystal deposits associated with tubulointerstitial nephropathy, Nephrol Dial Trans-plant, vol.13, pp.750-753, 1998.

A. Bihorac, C. Ozener, E. Akoglu, and S. Kullu, Tetracycline-induced acute interstitial nephritis as a cause of acute renal failure, Nephron, vol.81, issue.1, pp.72-77, 1999.

G. Namagondlu, S. E. Low, R. Seneviratne, and A. Banerjee, Acute renal failure from nitrofurantoin-induced acute granulomatous interstitial nephritis, QJM, vol.103, issue.1, pp.49-52, 2010.
DOI : 10.1093/qjmed/hcp146

URL : https://academic.oup.com/qjmed/article-pdf/103/1/49/4399077/hcp146.pdf

U. C. Brewster and M. A. Perazella, Acute interstitial nephritis associated with atazanavir, a new protease inhibitor, Am J Kidney Dis, vol.44, pp.81-85, 2004.

E. Curry, M. Thomas, and M. Yehia, Renal impairment and hypersensitivity reaction due to efavirenz, Nephrology (Carlton), vol.13, issue.6, 2008.

P. A. Hill, H. M. Prince, and D. A. Power, Tubulointerstitial nephritis following high-dose ifosfamide in three breast cancer patients, Pathology, vol.32, issue.3, pp.166-70, 2000.

K. Janssen-van-doorn, P. Van-der-niepen, F. Van-tussenbroeck, and D. Verbeelen, Acute tubulo-interstitial nephritis and renal infarction secondary to ergotamine therapy, Nephrol Dial Transplant, vol.15, issue.11, pp.1877-1886, 2000.

C. Estébanez, F. Reyes, M. J. , S. Hernández, R. Mon et al., Acute interstitial nephritis caused by clozapine, Nefrologia, vol.22, issue.3, pp.277-81, 2002.

R. Parekh, Z. Fattah, D. Sahota, and B. Colaco, Clozapine induced tubulointerstitial nephritis in a patient with paranoid schizophrenia, BMJ Case Rep, 2014.

S. Y. Chan, C. Y. Cheung, P. T. Chan, and K. F. Chau, Clozapine-induced acute interstitial nephritis, Hong Kong Med J, vol.21, issue.4, pp.372-376, 2015.

J. D. Kanofsky, M. E. Woesner, A. Z. Harris, J. P. Kelleher, K. Gittens et al., A case of acute renal failure in a patient recently treated with clozapine and a review of previously reported cases, Prim Care Companion CNS Disord, vol.13, issue.3, 2011.

T. J. Elias, K. M. Bannister, A. R. Clarkson, D. Faull, and R. J. Faull, Clozapine-induced acute interstitial nephritis, Lancet, vol.354, issue.9185, pp.1180-1181, 1999.

N. Y. An, J. Lee, and J. S. Noh, A Case of Clozapine Induced Acute Renal Failure, Psychiatry Investig, vol.10, issue.1, pp.92-96, 2013.

D. Fraser and M. Jibani, An unexpected and serious complication of treatment with the atypical antipsychotic drug clozapine, Clin Nephrol, vol.54, issue.1, pp.78-80, 2000.

D. S. Allan, C. M. Thompson, R. M. Barr, W. F. Clark, and C. Ih, Ciprofloxacin-associated hemolytic-uremic syndrome, Ann Pharmacother, vol.36, issue.6, pp.1000-1002, 2002.
DOI : 10.1345/1542-6270(2002)036<1000:cahus>2.0.co;2

H. R. Powell, P. M. Davidson, and D. A. Mccredie, Haemolytic-uraemic syndrome after treatment with metronidazole, Med J Aust, 1988.

P. J. Medina, J. M. Sipols, and J. N. George, Drug-associated thrombotic thrombocytopenic purpura-hemolytic uremic syndrome, Curr Opin Hematol, vol.8, pp.286-93, 2001.
DOI : 10.1097/00062752-200109000-00004

C. Canpolat, P. Pearson, and N. Jaffe, Cisplatin-associated hemolytic uremic syndrome, Cancer, vol.74, pp.3059-62, 1994.

R. Snanoudj, M. Rabant, V. Royal, N. Pallet, L. H. Noel et al., Nephrotoxicity of calcineurin inhibitors : presentation, diagnostic problems and risk factors, Néphrologie & Thérapeutique, vol.5, pp.365-70, 2009.

N. Pallet, E. Thervet, C. Legendre, and D. Anglicheau, Product Information: ZORTRESS(R) oral tablets, everolimus oral tablets. Novartis Pharmaceuticals Corporation (per FDA), Néphrologie & Thérapeutique, vol.2, issue.193, pp.183-90, 2006.

C. Larochelle, F. Grand&apos;maison, G. P. Bernier, M. Latour, J. F. Cailhier et al., Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome in relapsing-remitting multiple sclerosis patients on high-dose interferon ?, Mult Scler, vol.20, issue.13, pp.1783-1790, 2014.

C. L. Bennett, J. M. Connors, and J. M. Carwile, Thrombotic thrombocytopenic purpura associated with clopidogrel, N Engl J Med, 2000.

S. Feriozzi, A. O. Muda, V. Gomes, M. Montanaro, T. Faraggiana et al., Cephotaxime-associated allergic interstitial nephritis and MPO-ANCA positive vasculitis, Ren Fail, vol.22, issue.2, pp.245-51, 2000.

J. Borrás-blasco, R. Enriquez, and F. Amoros, Henoch-Schönlein purpura associated with clarithromycin. Case report and review of literature, Int J Clin Pharmacol Ther, vol.41, issue.5, pp.213-219, 2003.

D. J. Shih, S. M. Korbet, J. J. Rydel, and M. M. Schwartz, Renal vasculitis associated with ciprofloxacin, Am J Kidney Dis, vol.26, issue.3, pp.516-525, 1995.

S. A. Logan, M. Brown, and R. N. Davidson, Teicoplanin-induced vasculitis with cutaneous and renal involvement, J Infect, vol.51, issue.3, pp.185-191, 2005.

B. Salem, C. Hmouda, H. Slim, R. Denguezli, M. Belajouza et al., Rare case of metformin-induced leukocytoclastic vasculitis

, Ann Pharmacother, vol.40, issue.9, pp.1685-1692, 2006.

T. Hannedouche, Insuffisance rénale chronique. Epidémiologie et causes, 2008.

M. Daroux, C. Gaxatte, and F. Puisieux, Vieillissement rénal : facteurs de risque et néphroprotection, La Presse Médicale, vol.38, issue.11, pp.1667-79, 2009.

, Réseau Epidémiologie et Information en Néphrologie (REIN), 2014.

M. Laliberté, M. Normandeau, A. Lord, D. Lamarre, I. Cantin et al., Use of over-the-counter medications and natural products in patients with moderate and severe chronic renal insufficiency, Am J Kidney Dis Off J Natl Kidney Found, vol.49, issue.2, pp.442-450, 2007.

J. Jones, J. Holmen, D. Graauw, and J. , Association of complete recovery from acute kidney injury with incident CKD stage 3 and allcause mortality, Am J Kidney Dis, vol.60, pp.402-410, 2012.

A. Grapinet, Diagnostic de l'insuffisance rénale chronique chez l'adulte. Septembre, Place du pharmacien d'officine dans le parcours de soins du patient atteint de maladie rénale chronique : revue de la littérature et étude descriptive auprès des pharmaciens d'officine et du patient Th. : Pharm. : Grenoble : 2017 (208) Agence nationale d'accréditation et d'évaluation en santé (Anaes), 2002.

C. Legendre, Maladie rénale chronique. La revue du praticien, vol.62, pp.27-75, 2012.

A. Ahakoun, Le rôle de l'iatrogénie médicamenteuse dans l'insuffisance rénale et la prévention par le pharmacien Th, p.25, 2009.

R. Brik, D. Magen, O. Ben-yzhak, and J. Grin, Isoniazid-induced crescentic glomerulonephritis in a child with a positive tuberculin skin test

G. T. Shin, H. Yim, J. Park, and H. Kim, Membranous nephropathy associated with fluconazole treatment, Am J Kidney Dis, vol.18, issue.213, pp.318-340, 1998.
DOI : 10.1053/j.ajkd.2006.11.033

URL : http://repository.ajou.ac.kr/bitstream/201003/1251/3/318-322.pdf

G. S. Habib, W. Saliba, and M. Nashashibi, Penicillamine and nephrotic syndrome, Eur J Intern Med, vol.7, pp.343-351, 2006.
DOI : 10.1016/j.ejim.2006.03.001

V. K. Prasad, I. J. Lewis, and S. R. Aparicio, Progressive glomerular toxicity of ifosfamide in children, Med Pediatr Oncol, vol.27, issue.3, pp.149-55, 1996.

K. Kaneko, T. Nanki, T. Hosoya, F. Mizoguchi, and N. Miyasaka, Etanercept-induced necrotizing crescentic glomerulonephritis in two patients with rheumatoid arthritis, Mod Rheumatol, vol.20, issue.6, pp.632-638, 2010.

U. Tholl, M. Anlauf, and U. Helmchen, Clopidogrel and membranous nephropathy, Lancet, vol.354, issue.9188, pp.1443-1447, 1999.
DOI : 10.1016/s0140-6736(99)02586-6

G. S. Markowitz, J. Radhakrishnan, N. Kambham, A. M. Valeri, W. H. Hines et al., Lithium nephrotoxicity : a progressive combined glomerular and tubulointerstitial nephropathy, J Am Soc Nephrol, vol.11, issue.8, pp.1439-1487, 2000.

J. Thariat, J. N. Barrière, and J. , Renal tolerance of targeted therapies, Bull Cancer, vol.99, pp.317-339, 2012.

L. He, Y. Peng, X. Fu, X. Chen, and H. Liu, National Kidney Foundation Position Paper. Analgesics and the kidney: summary and recommendations to the scientific advisory board of the National Kidney Foundation from an Ad Hoc com-mittee of the National Kidney Foundation, Am J Kidney Dis, vol.35, issue.5, pp.162-167, 1996.

L. Lalande, B. Charpiat, G. Leboucher, and M. Tod, Consequences of renal failure on non-renal clearance of drugs, Clin Pharmacokinet, vol.53, pp.521-553, 2014.

J. Naud, T. D. Nolin, F. A. Leblond, and V. Pichette, Current understanding of drug disposition in kidney disease, J Clin Pharmacol, vol.52, issue.1, pp.10-22, 2012.

Z. H. Huang, T. Murakami, A. Okochi, R. Yumoto, J. Nagai et al., Expressionand function of P-glycoprotein in rats with glycerolinduced acute renal failure, Eur J Pharmacol, vol.406, pp.453-60, 2000.

T. Murakami, R. Yumoto, J. Nagai, and M. Takano, Factors affecting the expressionand function of P-glycoprotein in rats: drug treatments and diseased states, Pharmazie, vol.57, pp.102-109, 2002.

J. Naud, J. Michaud, C. Boisvert, K. Desbiens, F. A. Leblond et al., Down-regulation of intestinal drug transporters in chronic renal failure in rats, J Pharmacol Exp Ther, vol.320, pp.978-85, 2007.

S. Liabeuf, C. Villain, and Z. A. Massy, Protein-bound toxins : has the Cinderella of uraemic toxins turned into a princess ?, Clin Sci, vol.130, issue.23, pp.2209-2225, 2016.

J. Naud, C. Dumayne, T. D. Nolin, F. A. Leblond, and V. Pichette, Drug pharmacokinetics in renal failure : What's new ?, Néphrologie & Therapeutique, vol.11, pp.144-51, 2015.

T. J. Velenosi, A. Y. Fu, S. Luo, H. Wang, and B. L. Urquhart, Down-regulation of hepatic CYP3A and CYP2C mediated metabolism in rats with moderate chronic kidney disease, Drug Metab Dispos, vol.40, pp.1508-1522, 2012.

M. Tsujimoto, Y. Kinoshita, S. Hirata, M. Otagiri, H. Ohtani et al., Effects of uremic serum and uremic toxins on hepatic uptake of digoxin, Ther Drug Monit, vol.30, pp.576-82, 2008.

A. Rocha, M. Almeida, J. Santos, and A. Carvalho, Metformin in patients with chronic kidney disease: strengths and weaknesses, J Nephrol, vol.26, pp.55-60, 2013.

Y. Zhang, L. Zhang, S. Abraham, S. Apparaju, T. C. Wu et al., Assessment of the impact of renal impairment on systemic exposure of new molecular entities: evaluation of recent new drug applications, Clin Pharmacol Ther, vol.85, pp.305-316, 2009.

M. P. Marchandise, V. Gras, J. Moragny, J. Micallef, L. Gaboriau et al., ) ANSM. Rappel du bon usage de l'amoxicilline injectable pour diminuer le risque de cristalluries-Point d'information, British Journal of Clinical Pharmacology, vol.2017, issue.6, pp.1341-1350, 2018.

, Compte rendu de la réunion VIGIMED (départements 19, et 87). Limoges : VIGIMED, 25 septembre 2017, vol.23, pp.10-15

H. Mccormick, N. Tomaka, S. Baggett, T. Heierman, J. Lafosse et al., Comparison of acute renal injury associated with intermittent and extendedinfusion piperacillin/tazobactam, Am J Health Syst Pharm, vol.72, issue.11, pp.25-30, 20151.

T. Kim, S. Kandiah, M. Patel, R. S. Wong, J. Xue et al., Risk factors for kidney injury during vancomycin and piperacillin/tazobactam administration, including increased odds of injury with combination therapy, BMC Res Notes, vol.8, p.579, 2015.

L. D. Burgess and R. H. Drew, Comparison of the incidence of vancomycin-induced nephrotoxicity in hospitalized patients with and without concomitant piperacillin-tazobactam, Pharmacotherapy, vol.34, issue.7, pp.670-676, 2014.

F. Silverblatt, C. L. Leong, and T. Thiruventhiran, Pathogenesis of nephrotoxicity of cephalosporins and aminoglycosides: a review of current concepts, Rev Infect Dis, vol.4, issue.240, p.185, 1982.

H. J. Manley, G. R. Bailie, and G. Eisele, Bilateral renal cortical necrosis associated with cefuroxime axetil, Clin Nephrol, vol.49, issue.4, pp.268-70

G. Kapur, R. P. Valentini, T. K. Mattoo, I. Warrier, and A. A. Imam, Ceftriaxone induced hemolysis complicated by acute renal failure, Pediatr Blood Cancer, vol.50, issue.1, pp.139-181, 2008.

A. Seltsam and A. Salama, Ceftriaxone-induced immune haemolysis: two case reports and a concise review of the literature, Intensive Care Med, vol.26, issue.9, pp.1390-1394, 2000.

M. Punar, H. Ozsut, H. Eraksoy, S. Calangu, and M. Dilmener, An adult case of fatal hemolysis induced by ceftriaxone, Clin Microbiol Infect, vol.5, pp.585-591, 1999.

S. Chutipongtanate and V. Thongboonkerd, Ceftriaxone crystallization and its potential role in kidney stone formation, Biochem Biophys Res Commun, vol.406, issue.3, pp.396-402, 2011.

B. R. Dalton, D. J. Zuege, R. Shahpori, and K. B. Laupland, Concomitant ceftriaxone and high-concentration intravenous calcium therapy in adult critical care patients: a matched cohort study, Ann Pharmacother, vol.44, issue.7-8, pp.1158-63, 2010.

A. W. Mondorf, F. T. Heynold, J. E. Scherberich, H. Hess, and W. Schoeppe, Assessment of the nephrotoxic potential of ceftazidime and a ceftazidime/tobramycin combination in volunteers, Infection, vol.11, issue.1, pp.57-62, 1983.

A. Garnier, E. Marabet-el, H. Kwon, T. Peuchmaur, M. Mourier et al., Acute renal failure in a 3-year-old child as part of the drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome following hepatitis A, Am Fam Physician, vol.23, issue.4, pp.2527-2561, 2008.

A. Tone, K. Shikata, K. Nakagawa, M. Hashimoto, and H. Makino, Renoprotective effects of clarithromycin via reduction of urinary MCP-1 levels in type 2 diabetic patients, Clin Exp Nephrol, vol.15, issue.1, pp.79-85, 2011.

D. E. Butkus, A. De-torrente, and D. S. Terman, Renal failure following gentamicin in combination with clindamycin, Nephron, vol.17, issue.4, pp.307-320, 1976.

L. Storsley and L. Geldenhuys, Ciprofloxacin-induced ANCA-negative cutaneous and renal vasculitis resolution with drug with drawal, Nephrol Dial Transplant, vol.22, pp.660-661, 2007.

K. Shrishrimal, J. Wesson, and . Sulfamethoxazole, Am J Kidney Dis, vol.58, issue.3, pp.492-495, 2011.

H. Hyvernat, D. Swardt, P. Mondain, V. Bernardin, and G. , Insuffisance rénale aiguë obstructive lors d'un traitement par sulfadiazine, Press Med, vol.35, issue.3, pp.423-427, 2006.

K. M. Das, M. A. Eastwood, and J. P. Mcmanus, The metabolism of salicylazosulfapyridine in ulcerative colitis II. The relationship between metabolites and progress of the disease in outpatients, Gut, vol.14, pp.637-678, 1973.

U. Klotz, Clinical pharmacokinetics of sulphasalazine, its metabolites and other prodrugs of 5 aminosalicylic acid, Clin Pharmacokinet, vol.10, pp.285-302, 1985.

J. P. Gisbert, Y. Gonzalez-lama, and J. Mate, 5-Aminosalicylates and renal function in inflammatory bowel disease: a systematic review, Inflamm Bowel Dis, vol.13, issue.5, pp.629-667, 2007.

D. S. Pardi, W. J. Tremaine, and W. J. Sandborn, Renal and urologic complications of inflammatory bowel disease, Am J Gastroenterol, vol.93, issue.4, pp.504-518, 1998.

W. R. Smythe and J. E. Bavaria, Tetracycline pleurodesis associated acute renal failure, Chest, vol.104, issue.4, pp.1274-1280, 1993.
DOI : 10.1378/chest.104.4.1274

C. S. Miller and G. J. Mcgarity, Tetracycline-induced renal failure after dental treatment, J Am Dent Assoc, vol.140, issue.1, pp.56-60, 2009.
DOI : 10.14219/jada.archive.2009.0018

F. Rougier, D. Claude, and M. Maurin, Aminoglycoside Nephrotoxicity : Modeling, Simulation ; and control, Antimicrobial agents and chemotherapy, vol.47, issue.3, pp.1010-1016, 2003.
DOI : 10.1128/aac.47.3.1010-1016.2003

URL : https://hal.archives-ouvertes.fr/hal-00427460

A. Covic, O. Golea, and L. Segall, A clinical description of rifampicin-induced acute renal failure in 170 consecutive cases, J Indian Med Assoc, vol.102, issue.1, pp.22-27, 2004.

T. Muthukumar, M. Jayakumar, E. M. Fernando, and M. A. Muthusethupathi, Acute renal failure due to rifampicin : a study of 25 patients, Am J Kidney Dis, vol.40, issue.4, pp.690-696, 2002.

S. De-vriese-an, D. L. Robbrecht, R. C. Vanholder, D. P. Vogelaers, and N. H. Lameire, Rifampicin-associated acute renal failure : pathophysiology, immunologic and clinical features, Am J Kidney Dis, vol.31, pp.108-123, 1998.

Y. K. Wen and M. L. Chen, Crescentic glomerulonephritis associated with rifampicin in a patient co-infected with tuberculosis and human immunodeficiency virus, Clin Nephrol, vol.65, issue.4, pp.284-293, 2006.

C. Schubert, W. D. Bates, and M. R. Moosa, Acute tubulointerstitial nephritis related to antituberculous drug therapy, Clin Nephrol, vol.73, issue.6, pp.413-422, 2010.
DOI : 10.5414/cnp73413

H. K. Min, E. O. Kim, and S. J. Lee, Rifampin-associated tubulointersititial nephritis and Fanconi syndrome presenting as hypokalemic paralysis, BMC Nephrol, vol.14, p.13, 2013.
DOI : 10.1186/1471-2369-14-13

URL : https://bmcnephrol.biomedcentral.com/track/pdf/10.1186/1471-2369-14-13

F. Garcia-martin, F. Mampaso, G. De-arriba, F. Moldenhauer, E. Martin-escobar et al., Acute interstitial nephritis induced by ethambutol, Nephron, vol.59, issue.4, pp.679-80, 1991.

S. Namba, T. Igari, K. Nishiyama, K. Hashimoto, T. Takemura et al., A case of pyrazinamide-associated myoglobinuric renal failure

, Jpn J Med, vol.30, issue.5, pp.468-72, 1991.

S. Sanwikarja, R. H. Kauffmann, J. Te-velde, and J. Serlie, Tubulointerstitial nephritis associated with pyrazinamide, Neth J Med, vol.34, issue.1-2, pp.40-46, 1989.

G. Schoepp, Medication forum:Which patients are at the highest risk for NSAID-induced renal toxicity, and how can the risk be minimized?, Pharmacy Practice, vol.17, issue.6, pp.30-31, 2001.

G. Deray, Effets rénaux et cardiovasculaires des anti-inflammatoires non stéroïdiens et des coxib, Presse Med, vol.33, issue.7, pp.483-492, 2004.

Y. Lefebvre, . Les, J. Stoves, K. Rosenberg, P. Harnden et al., Acute interstitial nephritis due to over-the-counter ibuprofen in a renal transplant recipient, Canadian family physician, vol.21, issue.8, pp.227-235, 1975.

J. P. Tolins and P. Seel, Ibuprofen-induced interstitial nephritis and the nephrotic syndrome, Minn Med, vol.70, issue.9, pp.509-520, 1987.

C. Martin, N. Bruder, N. Pourriat, and J. , Pratique de la réanimation et de la médecine d'urgence. Paris : Arnette ; 2002. (278) Schoenmaker NJ, Weening JJ, Krediet RT. Ibuprofen-induced HUS, Clin Nephrol, vol.68, issue.3, pp.177-185, 2007.

M. Sivarajan and L. Wasse, Perioperative acute renal failure associated with preoperative intake of ibuprofen, Anesthesiology, vol.86, issue.6, pp.1390-1392, 1997.

P. A. Sheiner, E. Mor, and L. Chodoff, Acute renal failure associated with the use of ibuprofen in two liver transplant recipients on FK506, Transplantation, vol.57, issue.7, pp.293-298, 1994.

M. Schwartzman, D. &apos;agati, and V. , Spontaneous relapse of naproxen-related nephrotic syndrome, Am J Med, vol.82, issue.2, pp.329-361, 1987.

T. Revai and G. Harmos, Nephrotic syndrome and acute interstitial nephritis associated with the use of diclofenac, Wien Klin Wochenschr, vol.111, issue.13, pp.523-527, 1999.

T. Krummel, Y. Dimitrov, B. Moulin, and T. Hannedouche, Drug points: Acute renal failure induced by topical ketoprofen, BMJ, vol.320, issue.7227, p.93, 2000.
DOI : 10.1136/bmj.320.7227.93

URL : http://www.bmj.com/content/bmj/320/7227/93.full.pdf

W. Riess, K. Schmid, L. Botta, K. Kobayashi, J. Moppert et al., The percutaneous absorption of diclofenac, Arzneimittelforschung, vol.36, pp.1092-1098, 1986.

G. Berner, B. Engels, and U. Vogtle-junkert, Percutaneous ibuprofen therapy with Trauma-Dolgit gel: bioequivalence studies, Drugs Exp Clin Res, vol.15, pp.559-64, 1989.

V. Tsimihodimos, N. Psychogios, V. Kakaidi, E. Bairaktari, and M. Elisaf, ) Brater DC. Effects of nonsteroidal anti-inflammatory drugs on renal function: focus on cyclooxygenase-2-selective inhibition, Am J Kidney Dis, vol.50, issue.3, pp.65-71, 1999.

T. M. Clifford, M. Pajoumand, and T. D. Johnston, Celecoxib-induced nephrotoxicity in a renal transplant recipient, Pharmacotherapy, vol.25, issue.5, pp.773-780, 2005.

L. Akhund, R. J. Quinet, and S. Ishaq, Celecoxib-related renal papillary necrosis, Arch Intern Med, vol.163, issue.1, pp.114-119, 2003.
DOI : 10.1001/archinte.163.1.114

URL : http://espace.library.uq.edu.au/view/UQ:235909/UQ235909_fulltext.pdf

A. B. Alper, S. Meleg-smith, and N. K. Krane, Nephrotic syndrome and interstitial nephritis associated with celecoxib, Am J Kidney Dis, vol.40, issue.5, pp.1086-90, 2002.
DOI : 10.1053/ajkd.2002.36349

J. Henao, I. Hisamuddin, C. M. Nzerue, G. Vasandani, and K. Hewan-lowe, Celecoxib-induced acute interstitial nephritis, Am J Kidney Dis, vol.39, issue.6, pp.1313-1320, 2002.
DOI : 10.1053/ajkd.2002.33412

G. S. Markowitz, D. C. Falkowitz, R. Isom, M. Zaki, S. Imaizumi et al., Membranous glomerulopathy and acute interstitial nephritis following treatment with celecoxib, Clin Nephrol, vol.59, issue.2, pp.137-179, 2003.

M. Almansori, T. Kovithavongs, and M. U. Qarni, Cyclooxygenase-2 inhibitor-associated minimal-change disease, Clin Nephrol, vol.63, issue.5, pp.381-385, 2005.
DOI : 10.5414/cnp63381

I. Cobden, C. O. Record, M. K. Ward, and D. N. Kerr, Paracetamol-induced acute renal failure in the absence of fulminante liver damage, Br Med J (Cin Res Ed), vol.284, issue.6308, pp.21-23, 1982.

L. F. Prescott, A. T. Proudfoot, and R. J. Cregeen, Paracetamol-induced acute renal failure in the absence of fulminant liver damage, Br Med J (Clin Res Ed), vol.284, issue.6313, pp.421-423, 1982.

W. S. Waring, H. Jamie, and G. E. Leggett, Delayed onset of acute renal failure after significant paracetamol overdose : A case series, Hum Exp Toxicol, vol.29, issue.1, pp.63-71, 2010.

Y. G. Chen, C. L. Lin, M. S. Dai, P. Y. Chang, J. H. Chen et al., Risk of acute kidney injury and long-term outcome in patients with acetaminophen intoxication : a nationwide population-based retrospective cohort study, Medicine (Baltimore), vol.94, issue.46, p.2040, 2015.

N. R. Campbell and B. Baylis, Renal impairment associated with an acute paracetamol overdose in the absence of hepatotoxicity, Postgrad Med J, vol.68, issue.796, pp.116-124, 1992.

O. Ozkaya, G. Genc, K. Bek, and Y. Sullu, A case of acetaminophen (paracetamol) causing renal failure without liver damage in a child and review of literature, Ren Fail, vol.32, issue.9, pp.1125-1132, 2010.

M. A. Von-mach, M. Hermanns-clausen, I. Koch, J. G. Hengstler, M. Lauterbach et al., Experiences of a poison center network with renal insufficiency in acetaminophen overdose: an analysis of 17 cases, Clin Toxicol (Phila), vol.43, issue.1, pp.1-7, 2005.

J. L. Stollings, A. P. Wheeler, and T. W. Rice, Incidence and characterization of acute kidney injury after acetaminophen overdose, J Crit Care, vol.35, pp.191-195, 2016.

K. Moore, Renal failure in acute liver failure, Eur J Gastroenterol Hepatol, vol.11, issue.9, pp.967-75, 1999.

J. A. Leithead, J. W. Ferguson, C. M. Bates, J. S. Davidson, A. Lee et al., The systemic inflammatory response syndrome is predictive of renal dysfunction in patients with non-paracetamol-induced acute liver failure, Gut, vol.58, issue.3, pp.443-452, 2009.

R. W. Curry, J. D. Robinson, and M. J. Sughrue, Acute renal failure after acetaminophen ingestion, JAMA, vol.247, issue.7, pp.1012-1016, 1982.

S. Dabbagh and R. W. Chesney, Acure renal failure related to acetaminophen (paracetamol) overdose without fulminant hepatic disease, Int J Pediatr Nephrol, vol.6, issue.3, pp.221-225, 1985.

G. Stegeman-castelen, J. Van-hattum, H. A. Koomans, J. De-vries, and A. N. Van-heijst, {Acute kidney insufficiency following paracetamol poisoning}, Ned Tijdschr Geneeskd, vol.127, issue.24, pp.1052-1056, 1983.

K. Kedzierska, M. Myslak, E. Kwiatkowska, J. Bober, J. Rozanski et al., Acute renal failure after paracetamol (acetaminophen) poisoning-report of two cases, Wiad Lek, vol.56, pp.587-90, 2003.

A. Ammenti, R. Ferrante, and A. Spagne, Renal impairment without hepatic damage after acetaminophen overdose, Pediatr Nephrol, vol.13, issue.3, pp.271-273, 1999.

K. Kher and S. Makker, Acute renal failure due to acetaminophen ingestion without concurrent hepatotoxicity, Am J Med, vol.82, issue.6, pp.1280-1281, 1987.

J. R. Mitchell, D. J. Jollow, W. Z. Potter, D. C. Davis, J. R. Gillette et al., Acetaminophen-induced hepatic necrosis. I. Role of drug metabolism, J Pharmacol Exp Ther, vol.187, issue.1, pp.185-94, 1973.

W. S. Waring, A. Stephen, A. M. Malkowska, and O. Robinson, Acute acetaminophen overdose is associated with dose-dependent hypokalaemia : a prospective study of 331 patients, Basic Clin Pharmacol Toxicol, vol.102, issue.3, pp.325-333, 2008.

B. Hinz, O. Cheremina, and K. Brune, Acetaminophen (paracetamol) is a selective cyclooxygenase 2 inhibitor in man, FASEB J, vol.22, issue.2, pp.383-90, 2008.

L. Eguia and B. J. Materson, Acetaminophen-related acute renal failure without fulminant liver failure, Pharmacotherapy, vol.17, issue.2, pp.363-70, 1997.

P. Blakely and B. R. Mcdonald, Acute renal failure due to acetaminophen ingestion : a case report and review of the literature, J Am Soc Nephrol, vol.6, issue.1, pp.48-53, 1995.

R. Afshari and H. Ghooshkhanehee, Tramadol overdose induced seizure, dramatic rise of CPK and acute renal failure, J Pak Med Assoc, vol.59, issue.3, p.178, 2009.

D. Kleinknecht, O. Kourislky, and L. Morel-maroger, Dense deposit disease with rapidly progressive renal failure in a narcotic addict

, Clin Nephrol, vol.14, pp.309-321, 1980.

P. Zaoui, N. Bourmeyester, and D. Cordonnier, Le système rénine-angiotensine et la progression de l'insuffisance rénale. Collection pathologie science formation, p.154, 1997.

B. M. Brenner, M. E. Cooper, and D. De-zeeuw, Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy, N Engl. J. Med, vol.345, pp.861-870, 2001.

. Anaes, Recommandations pour la pratique clinique : Moyens thérapeutiques pour ralentir la progression de l'insuffisance rénale chronique chez l'adulte

L. F. Fried, N. Emanuele, J. H. Zhang, M. Brophy, T. A. Conner et al., Combined Angiotensin Inhibition for the Treatment of Diabetic Nephropathy, N Engl J Med, vol.369, issue.20, pp.1892-903, 2013.

T. Krummel, A. L. Faller, D. Bazin, and T. Hannedouche, Les promesses de la néphroprotection à l'épreuve des faits, Presse Med, vol.40, pp.1037-1079, 2011.

K. M. Denton, P. A. Fennessy, D. Alcorn, and W. P. Anderson, Morphometric analysis of the actions of angiotensin II on renal arterioles and glomeruli, Am J Physiol, vol.262, issue.3, pp.367-72, 1992.

H. P. Hansen, P. Rossing, L. Tarnow, F. S. Nielsen, B. R. Jensen et al., Increased glomerular filtration rate after withdrawal of long-term antihypertensive treatment in diabetic nephropathy, Kidney Int, vol.47, issue.6, pp.1726-1757, 1995.

J. T. Santoso, J. A. Lucci, R. L. Coleman, I. Schafer, and E. V. Hannigan, Saline, mannitol, and furosemide hydration in acute cisplatin nephrotoxicity: a randomized trial, Cancer Chemother Pharmacol, vol.52, issue.1, pp.13-21, 2003.

G. Marenzi, C. Ferrari, I. Marana, E. Assanelli, D. Metrio et al., Prevention of contrast nephropathy by furosemide with matched hydration: the MYTHOS (Induced Diuresis With Matched Hydration Compared to Standard Hydration for Contrast Induced Nephropathy Prevention) trial, JACC Cardiovasc Interv, vol.5, issue.1, pp.90-97, 2012.

R. Enriquez, J. B. Cabezuelo, C. Gonzalez, J. Lacueva, A. Teruel et al., Granulomatous interstitial nephritis associated with hydrochlorothiazide/amiloride, Am J Nephrol, vol.15, issue.3, pp.270-273, 1995.

A. B. Magil, H. S. Ballon, E. C. Cameron, and R. A. , Acute interstitial nephritis associated with thiazide diuretics. Clinical and pathologic observations in three cases, Am J Med, vol.69, issue.6, pp.939-982, 1980.

R. Rachmani, I. Slavachevsky, and M. Amit, The effects of spironolactone, cilazapril and their combination on albuminuria in patients with hypertension and diabetic nephropathy is independent of blood pressure reduction: a randomized controlled study, Diabetes Med, vol.21, pp.471-476, 2004.

A. Sato, K. Hayashi, and T. Saruta, Effectiveness of aldosterone blockade in patients with diabetic nephropathy, Hypertension, vol.41, pp.64-72, 2003.

S. Bianchi, R. Bigazzi, and V. M. Campese, Antagonists of aldosterone and proteinuria in patients with CKD: an uncontrolled pilot study, Am J Kidney Dis, vol.46, pp.45-51, 2005.

U. F. Mehdi, B. Adams-huet, P. Raskin, G. L. Vega, and R. D. Toto, Addition of angiotensin receptor blockade or mineralocorticoid antagonism to maximal angiotensin-converting enzyme inhibition in diabetic nephropathy, J Am Soc Nephrol, vol.20, pp.2641-50, 2009.

N. C. Edwards, R. P. Steeds, C. D. Chue, P. M. Stewart, C. J. Ferro et al., The safety and tolerability of spironolactone in patients with mild to moderate chronic kidney disease, Br J Clin Pharmacol, vol.73, issue.3, pp.447-54, 2012.

S. Bianchi, R. Bigazzi, and V. M. Campese, Long-term effects of spironolactone on proteinuria and kidney function in patients with chronic kidney disease, Kidney Int, vol.70, issue.12, pp.2116-2139, 2006.

A. S. Bomback and P. J. Klemmer, Mineralocorticoid Receptor Blockade in Chronic Kidney Disease, Blood Purif, vol.33, issue.1-3, pp.119-124, 2012.

N. Grenier, Prévention de la néphrotoxicité des produits de contraste iodés, Feuillets de Radiologie, vol.45, issue.3, pp.13-19, 2005.

K. Nash, A. Hafeez, and S. Hou, Hospital-acquired renal insufficiency, Am J Kidney Dis, vol.39, issue.5, pp.930-936, 2002.

L. Laroussi, M. Triki, I. Elhaj, Z. , B. Halima et al., Vitamine C + sérum bicarbonaté versus sérum bicarbonate seul dans la prévention de la néphropathie induite par les produits de contraste, Annales de Cardiologie et, vol.66, pp.190-196, 2017.

S. Karie, V. Launay-vacher, H. Izzedine, and G. Deray, L'épuration extra-rénale est-elle efficace en prévention de la néphropathie induite par les produits de contraste iodés, Presse Med, vol.34, issue.11, pp.803-811, 2005.

G. Deray, Prévention de la toxicité des produits de contraste iodés, Bull Soc Toxicol Clin, vol.12, p.6, 2001.

P. Aspelin, P. Aubry, S. G. Fransson, R. Strasser, R. Willenbrock et al., Nephrotoxicity in high-risk patients study of iso-osmolar and lowosmolar non-ionic contrast media study investigators. Nephrotoxic effects in high-risk patients undergoing angiography, N Engl J Med, vol.348, pp.491-500, 2003.

K. J. Berg, ) Berns AS. Nephrotoxicity of contrast media, Scand J Urol Nephrol, vol.34, issue.343, pp.730-770, 1989.

C. S. Rihal, S. C. Textor, D. E. Grill, P. B. Berger, H. H. Ting et al., Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention, Circula-tion, vol.105, pp.2259-64, 2002.

M. R. Rudnick, S. Goldfarb, L. Wexler, P. A. Ludbrook, M. J. Murphy et al., Nephrotoxicity of ionic and nonionic contrast media in 1 196 patients: a randomized trial. The Iohexol Cooperative Study, Kidney Int, vol.47, pp.254-61, 1995.

S. J. Schwab, M. A. Hlatky, K. S. Pieper, C. J. Davidson, K. G. Morris et al., Contrast nephrotoxicity: a randomized controlled trial of a nonionic and an ionic radiographic contrast agent, N Engl J Med, vol.320, pp.149-53, 1989.

S. Amet and . Zimner-rapuch, Toxicité rénale des produits de contraste chez le patient insuf sant rénal Quelles options en pratique ?, Onko Plus, vol.2, pp.209-225, 2010.

B. J. Barrett and E. J. Carlisle, Metaanalysis of the relative nephrotoxicity of high-and low-osmolarity iodinated contrast media, Radiology, vol.188, pp.171-179, 1993.

R. E. Katholi, D. J. Taylor, and W. T. Woods, Nephrotoxicity of nonionic low-osmolarity versus ionic high-osmolarity contrast media : A prospective double-blind randomized comparison in human beings, Radiology, vol.186, pp.183-190, 1993.

D. Reddan, M. Laville, and V. D. Garovic, Contrast-induced nephropathy and its prevention : What do we really know from evidence-based findings?, J Nephrol, vol.22, issue.3, pp.333-51, 2009.

S. K. Morcos, Prevention of contrast media nephrotoxicity-the story so far, Clin Radiol, vol.59, issue.5, pp.381-390, 2004.

G. J. Merten, W. P. Burgess, and L. V. Gray, Prevention of contrast-induced nephropathy with sodium bicarbonate : a randomized controlled trial, Neth J Med, vol.291, issue.353, pp.416-438, 2004.

R. G. Cigarroa, R. A. Lange, and R. H. Williams, Dosing of contrast material to prevent contrast nephropathy in patients with renal disease

, Am J Med, vol.86, pp.649-52, 1989.

T. Duy-khiem, A. Gairard-dory, A. C. Alt, M. Beretz, and L. , Néphrotoxicité induite par les produits de contraste iodés et prévention par la Nacétylcystéine, Journal de Pharmacie Clinique, vol.23, issue.1, pp.19-23, 2004.

F. Sierra, M. Suarez, M. Rey, and M. F. Vela, Systematic review : Proton pump inhibitor-associated acute interstitial nephritis, Aliment Pharmacol Ther, vol.26, issue.4, pp.545-53, 2007.

I. J. Simpson, M. R. Marshall, and H. Pilmore, Proton pump inhibitors and acute interstitial nephritis: report and analysis of 15 cases, Nephrology (Carlton), vol.11, issue.5, pp.381-386, 2006.

L. Härmark, H. E. Van-der-wiel, M. C. De-groot, and A. C. Van-grootheest, Proton pump inhibitor-induced acute interstitial nephritis, Br J Clin Pharmacol, vol.64, issue.6, pp.819-842, 2007.

N. Torpey, T. Barker, and C. Ross, Drug-induced tubulo-interstitial nephritis secondary to proton pump inhibitors : experience from a single UK renal unit, Nephrol Dial Transplant, vol.19, issue.6, pp.1441-1447, 2004.

N. Geevasinga, P. L. Coleman, and S. D. Roger, Rabeprazole-induced acute interstitial nephritis, Nephrology (Carlton), vol.10, issue.1, pp.7-9, 2005.

A. Ra and S. W. Tobe, Acute interstitial nephritis due to pantoprazole, Ann Pharmacother, vol.38, issue.1, pp.41-46, 2004.

G. Desbuissons, G. Deray, and L. Mercadal, Inhibiteurs de la pompe à proton et rein, Néphrologie & Thérapeutiques, 2017.

,

D. G. Moledina and M. A. Perazella, Proton Pump Inhibitors and CKD, J Am Soc Nephrol, vol.27, issue.10, pp.2926-2934, 2016.

B. Lazarus, Y. Chen, F. P. Wilson, Y. Sang, A. R. Chang et al., Proton pump inhibitors and the risk of chronic kidney disease, JAMA Intern Me, vol.176, pp.238-284, 2016.

Y. Xie, B. Bowe, T. Li, H. Xian, S. Balasubramanian et al., Proton Pump Inhibitors and Risk of Incident CKD and Progression to ESRD, J Am Soc Nephrol, vol.27, issue.10, pp.3153-63, 2016.

M. Fusaro, S. Giannini, and M. Gallieni, Adverse Effects of Proton Pump Inhibitors in Chronic Kidney Disease, JAMA Intern Med, vol.176, issue.6, p.866, 2016.

G. Yepuri, R. Sukhovershin, T. Z. Nazari-shafti, M. Petrascheck, Y. T. Ghebre et al., Proton Pump Inhibitors Accelerate Endothelial Senescence, Circ Res, vol.10, issue.12, pp.36-42, 2016.

R. Poesen, B. Meijers, and P. Evenepoel, Adverse Effects of Proton Pump Inhibitors in Chronic Kidney Disease, JAMA Intern Med, vol.176, issue.6, pp.867-875, 2016.

, Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults, De beers By the American Geriatrics Society 2015 Beers Criteria Update Expert Panel, vol.63, pp.2227-2273, 2015.

B. Aloy, P. Y. Desplanques, S. Gurgel, G. Deray, and V. Launay-vacher, Médicaments et insuffisances rénale. Actualités pharmaceutiques, vol.572, pp.33-39, 2018.

S. D. Weisbord, J. B. Soule, and P. L. Kimmel, Poison on lineeacute renal failure caused by oil of wormwood purchased through the Internet

, Engl. J. Med, vol.337, issue.12, pp.825-832, 1997.

S. Aloui, H. Skhiri, A. Ltaief, and M. Elmay, An exceptional case of acute renal failure: is there a renal toxicity of Artemisia herba-alba?, Ren. Fail, vol.32, issue.8, pp.1009-1020, 2010.

O. Dori, A. Humbert, and M. Burnier, Risques rénaux des compléments alimentaires : une cause ignorée, Revue Médicale Suisse, vol.10, pp.498-503, 2014.

S. Gabardi, K. Munz, and C. Ulbricht, A review of dietary supplement-indiced renal dysfunction, J Am Soc Nephrol, vol.2, pp.757-65, 2007.

E. E. St-john-;-turton-weeks, S. M. Barone, G. W. Gurley, B. J. Ketel, B. L. Lightfoot et al., s Wort supplements endanger the success of organ trans-plantation, Arch. Surg, vol.137, issue.3, pp.316-325, 2002.

. Prog, Transpl, vol.11, issue.2, pp.116-136, 2001.

S. Mashour, T. Jr, J. F. Merrell, and R. , Acute renal failure, oxalosis, and vitamin C supplementation: a case report and review of the literature, Chest, vol.118, issue.2, pp.561-564, 2000.

S. H. Allen and J. H. Shah, Calcinosis and metastatic calcification due to vitamin D intoxication. A case report and review, Horm. Res, vol.37, issue.1e2, pp.68-77, 1992.

A. An?k, G. Çatl?, A. Abac?, C. Dizdarer, and E. Bober, Acute vitamin D intoxication possibly due to faulty production of a multivitamin preparation, J. Clin. Res. Pediatr. Endocrinol, vol.5, issue.2, pp.136-145, 2013.

G. Conti, V. Chirico, A. Lacquaniti, L. Silipigni, C. Fede et al., Vitamin D intoxication in two brothers: be careful with dietary supplements, J. Pediatr. Endocrinol. Metab, vol.27, issue.7e8, pp.763-770, 2014.

F. Granado-lorencio, E. Rubio, I. Blanco-navarro, B. Perez-sacrista, R. Rodríguez-pena et al., hypervitaminosis A and 3-epi-25-OH-D3 levels after consumption of an "over the counter" vitamin D remedy. a case report, Food Chem. Toxicol, vol.50, issue.6, pp.2106-2114, 2012.

P. Koutkia, T. C. Chen, and M. F. Holick, Vitamin D intoxication associated with an over-the-counter supplement, N. Engl. J. Med, vol.345, issue.1, pp.66-73, 2001.

D. Hammoud, E. Haddad, B. Abdallah, and J. , Hypercalcaemia secondary to hypervitaminosis a in a patient with chronic renal failure, West Indian Med. J, vol.63, issue.1, pp.105-113, 2014.

K. H. Safi, A. G. Filbrun, and S. Z. Nasr, Hypervitaminosis A causing hypercalcemia in cystic fibrosis. Case report and focused review, Ann. Am. Thorac. Soc, vol.11, issue.8, pp.1244-1251, 2014.

H. E. Yim, K. H. Yoo, W. H. Seo, N. H. Won, Y. S. Hong et al., Acute tubulointerstitial nephritis following ingestion of Chlorella tablets, Pediatr. Nephrol, vol.22, issue.6, pp.887-895, 2007.

J. Cerulli, D. W. Grabe, I. Gauthier, M. Malone, and M. D. Mcgoldrick, Chromium picolinate toxicity, Ann. Pharmacother, vol.32, issue.4, pp.428-459, 1998.

K. M. Koshy, E. Griswold, and E. E. Schneeberger, Interstitial nephritis in a patient taking creatine, N. Engl. J. Med, vol.340, pp.814-819, 1999.

V. K. Audimoolam and S. Bhandari, Acute interstitial nephritis induced by glucosamine, Nephrol. Dial. Transpl, vol.21, issue.7, p.2031, 2006.

M. I. Hainer, N. Tsai, S. T. Komura, and C. L. Chiu, Fatal hepatorenal failure associated with hydrazine sulfate, Ann. Intern Med, vol.133, issue.11, pp.877-80, 2000.

P. Queneau and P. Grandmottet, Prévention de la iatrogénie évitable : le devoir de vigilance, Presse Med, vol.27, pp.1280-1282, 1998.

J. Lazarou, B. H. Pomeranz, and P. N. Corey, Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies, JAMA, vol.279, pp.1200-1205, 1998.

A. Castot, F. Haramburu, C. Kreft-jais, and . Afssaps, Hospitalisations dues aux effets indésirables des médicaments: résultats d'une étude nationale, 2008.

F. Pouzaud and L. Tranthimy, La convention déploie de nouvelles fonctions, Le moniteur des pharmacie, vol.3187, pp.15-22, 2017.

M. Labetoulle, La iatrogénie : quelle ampleur, pourquoi et comment la réduire, Journal français d'ophtalmologie, vol.32, pp.79-82, 2009.

C. Chittaro, Effets indésirables médicamenteux associés aux motifs d'hospitalisation : étude descriptive dans une unité de soins de néphrologie au CHU de Grenoble Th, 2015.

H. S. Blix, K. K. Viktil, T. A. Moger, and A. Reikvam, Use of renal risk drugs in hospitalized patients with impaired renal function-an underestimated problem?, Nephrol Dial Transplant, vol.21, pp.3164-71, 2006.

B. Ponte, P. Saudan, E. M. Levy, C. M. Viscoli, and R. I. Horwitz, The effect of acute renal failure on mortality. A cohort analysis, Rev Méd Suisse, vol.4, issue.399, pp.1489-94, 1996.

H. R. Brady and G. G. Singer, Acute renal failure, Lancet, vol.346, pp.1533-1573, 1995.

S. Uchino, J. A. Kellum, and R. Bellomo, Acute renal failure in critically ill patients : a multinational, multicenter study, JAMA, vol.294, pp.813-821, 2005.

P. Li, E. A. Burdmann, R. Mehta, M. A. Via-sosa, N. Lopes et al., Effectiveness of a drug dosing service provided by community pharmacists in polymedicated elderly patients with renal impairment-a comparative study, BMC Family Practice, vol.95, issue.403, p.96, 2013.

K. D. Barnes, N. H. Tayal, A. M. Lehman, and S. J. Beatty, Pharmacist-driven renal medication dosing intervention in a primary care patientcentered medical home, Pharmacotherapy, vol.34, issue.12, pp.1330-1335, 2014.

X. Pourrat, A. S. Sipert, P. Gatault, B. Sautenet, N. Hay et al., Community pharmacist intervention in patients with renal impairment, Int J Clin Pharm, vol.37, issue.6, pp.1172-1181, 2015.

, Cour des comptes. Chapitre X. L'insuffisance rénale chronique terminale : favoriser des prises en charge plus efficientes, 2015.

, Ministère de la santé et des sports. La loi HPST, les clés pour comprendre, 2018.

. Ars-nord-pas-de-calais, Plan de gestion des risques 2010-2013, 2018.

H. Leriverend, J. Rabillet, and S. Faure, Connaissance de la fonction rénale lors de la délivrance de médicaments : une avancée dans la prise en charge, Actualités pharmaceutiques, vol.557, pp.31-35, 2016.

G. Valente, L. Rinaldi, M. Sgambato, and G. Piai, Conversion from twice-daily to once-daily tacrolimus in stable liver transplant patients : effectiveness in a real-world setting, Transplant Proc, vol.45, issue.3, pp.1273-1278, 2013.

V. Launay-vacher, J. B. Rey, and C. Isnard-bagnis, European society of clinical pharmacy special interest group on cancer care. Prevention of cisplatin nephrotoxicity: state of the art and recommendations from the European society of clinical pharmacy special interest group on cancer care, Cancer Chemother Pharmacol, vol.61, issue.412, pp.903-912, 2008.

V. Launay-vacher, E. Chatelut, S. M. Lichtman, H. Wildiers, C. Steer et al., International Society of Geriatric Oncology. Renal insufficiency in elderly cancer patients: International Society of Geriatric Oncology clinical practice recommendations, Ann Oncol, vol.18, issue.8, pp.1314-1335, 2007.

Z. Ying, C. Guan, and N. Huang, Single high-dose and fractionated low dose cisplatin in the EP protocol for advanced NSCLC-a prospective randomized trial on 72 patients, Zhonghua Zhong Liu Za Zhi, vol.17, issue.3, pp.226-234, 1995.

G. Deray and A. Baumelou, La prévention de la néphrotoxicité aigue médicamenteuse. Est ce possible ?, Presse Med, vol.17, pp.1607-1615, 1988.

L. Thatte and C. A. Vaamonde, Drug-induced nephrotoxicity : the crucial role of risk factors, Postgrad Med, vol.100, pp.83-87, 1996.

G. Pazhayattil and A. Shirali, Drug-induced impairment of renal function, International Journal of Nephrology and Renovascular Disease. 12 decembre, vol.7, pp.457-68, 2014.

F. Lapi, L. Azoulay, H. Yin, S. J. Nessim, and S. Suissa, Concurrent use of diuretics, angiotensin converting enzyme inhibitors, and angiotensin receptor blockers with non-steroidal anti-inflammatory drugs and risk of acute kidney injury : nested case-control study, BMJ, vol.346, pp.1-11, 2013.

T. Dreischulte, D. R. Morales, S. Bell, and B. Guthrie, Combined use of nonsteroidal anti-inflammatory drugs with diuretics and/or reninangiotensin system inhibitors in the community increases the risk of acute kidney injury, Kidney Int, vol.88, issue.2, pp.396-403, 2015.

D. W. Frank, J. E. Gray, and R. N. Weaver, Cyclodextrin nephrosis in the rat, Am J Pathol, vol.83, pp.367-82, 1976.

F. C. Hugues, Les facteurs de risques d'accidents médicamenteux chez l'adulte, J Pharm Clin, vol.16, issue.3, pp.157-64, 1997.

M. A. Perazella, Onco-nephrology: renal toxicities of chemothera-peutic agents, Clin J Am Soc Nephrol, vol.7, pp.1713-1734, 2012.

A. Boyer, D. Gruson, and S. Bouchet, Aminoglycosides in septic shock: an overview, with speci c consideration given to their nephrotoxic risk, Drug Saf, vol.36, pp.217-247, 2013.

S. Belaiche, E. Mercier, D. Cuny, N. Kambia, P. Wierre et al., Community pharmacists' interventions to prevent and screen chronic kidney disease patients, Nephrologie & Thérapeutique, vol.13, pp.87-92, 2017.

M. C. Laliberté, M. Normandeau, A. Lord, D. Lamarre, I. Cantin et al., Use of over-the-counter medications and natural products in patients with moderate and severe chronic renal insufficiency, American Journal of Kidney Diseases, vol.49, issue.2, pp.245-56, 2007.

D. W. Grabe and G. D. Garrison, Comparison of natural product use between primary care and nephrology patients, Ann Pharmacother, vol.38, issue.7-8, pp.1169-72, 2004.

S. Zimner-rapuch and V. Launay-vacher, Adaptation posologique des médicaments chez le patient insuffisant rénal chronique, J Pharm Clin, vol.30, issue.4, pp.223-231, 2011.

, ANSM, Déclaration des effets indésirables, 2018.

L. Zhu, A. Fox, and Y. C. Chan, Enhancing collaborative pharmaceutical care for patients with chronic kidney disease: survey of community pharmacists, Can J Hosp Pharm, vol.67, issue.4, pp.268-73, 2014.

Y. Kondo, Y. Ishitsuka, E. Shigemori, M. Irikura, D. Kadowaki et al., Awareness and current implementation of drug dosage adjustment by pharmacists in patients with chronic kidney disease in Japan: a web-based survey, BMC Health Services Research, vol.14, issue.431, p.615, 2014.

L. Lefevre, Déterminants de l'intégration de la fonction rénale sur les ordonnances médicamenteuses par les médecins en France : étude qualitative par entretiens semi-dirigés Th, p.2017

A. Geerts, N. D. Scherpbier-de-haan, F. De-koning, T. Van-der-sterren, C. Van-weel et al., A pharmacy medication alert system based on renal function in older patients, Britich Journal of General Practice, vol.62, issue.601, pp.525-554, 2012.

L. Lalonde, M. Normandeau, D. Lamarre, A. Lord, D. Berbiche et al., Evaluation of a training and communication-network nephrology program for community pharmacists, Pharm World Sci, vol.30, issue.6, pp.924-957, 2008.

M. È. Legris, N. C. Séguin, K. Desforges, P. Sauvé, A. Lord et al., Pharmacist Web-based training program on medication use in chronic kidney disease patients: impact on knowledge, skills, and satisfaction, J Contin Educ Health Prof, vol.31, issue.3, pp.140-50, 2011.

A. Mckinnon and D. Jorgenson, Pharmacist and physician collaborative prescribing: for medication renewals within a primary health centre, Canadian Family Physician, vol.55, issue.12, pp.86-91, 2009.

M. Clausener, Code de la Santé Publique. Article L 1161-1, 2017, année des messageries sécurisées. Le moniteur des pharmacies, vol.2017, pp.16-23, 2009.

&. Texte=&amp;categorielien=cid, Consulté le 5 mars, 2018.